Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No association between genetic polymorphisms in insulin and insulin receptor substrate-1 and prostate cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Oct 2005

Li Li, Cicek Mine S, Casey Graham, Witte John S

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Insulin
Share to Insulin Receptor Substrate Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phosphoproteins

Share to Polymorphism, Genetic

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 16214935
DOI: 10.1158/1055-9965.EPI-05-0531

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No association between genetic polymorphisms in insulin and insulin receptor substrate-1 and prostate cancer.PMID 16214935Read ↗

Insulin resistance-related gene polymorphisms and risk of prostate cancer.Semantic proximity Read ↗

No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk.Semantic proximity Read ↗

Insulin receptor H1085H C>T and insulin receptor substrate 1 G972R polymorphisms and prostate cancer risk: a pilot study.Semantic proximity Read ↗

An assessment of the shared allelic architecture between type II diabetes and prostate cancer.Semantic proximity Read ↗

Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).Semantic proximity Read ↗

No association between genetic polymorphisms in IGF-I and IGFBP-3 and prostate cancer.Semantic proximity Read ↗

An intronic variant in PTEN is not associated with prostate cancer risk.Semantic proximity Read ↗

Polymorphism of the insulin gene is associated with increased prostate cancer risk.Semantic proximity Read ↗

Lack of association of transforming growth factor-beta1 polymorphisms and haplotypes with prostate cancer risk in the prostate, lung, colorectal, and ovarian trial.Semantic proximity Read ↗

Genetic variation in insulin pathway genes and distal colorectal adenoma risk.Semantic proximity Read ↗

Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndromeSemantic proximity Read ↗

Mutations in the coding region of the insulin promoter factor 1 gene are not a common cause of maturity-onset diabetes of the young in Japanese subjects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.